These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 19669642)
1. Tumors induce the formation of suppressor endothelial cells in vivo. Mulligan JK; Young MR Cancer Immunol Immunother; 2010 Feb; 59(2):267-77. PubMed ID: 19669642 [TBL] [Abstract][Full Text] [Related]
2. Tumors skew endothelial cells to disrupt NK cell, T-cell and macrophage functions. Mulligan JK; Lathers DM; Young MR Cancer Immunol Immunother; 2008 Jul; 57(7):951-61. PubMed ID: 18058097 [TBL] [Abstract][Full Text] [Related]
3. Tumor secretion of VEGF induces endothelial cells to suppress T cell functions through the production of PGE2. Mulligan JK; Rosenzweig SA; Young MR J Immunother; 2010; 33(2):126-35. PubMed ID: 20145550 [TBL] [Abstract][Full Text] [Related]
4. NK-dependent increases in CCL22 secretion selectively recruits regulatory T cells to the tumor microenvironment. Mailloux AW; Young MR J Immunol; 2009 Mar; 182(5):2753-65. PubMed ID: 19234170 [TBL] [Abstract][Full Text] [Related]
5. Differential induction of suppressor macrophages by cloned Lewis lung carcinoma variants in mice. Young MR; Newby M J Natl Cancer Inst; 1986 Dec; 77(6):1255-60. PubMed ID: 3491925 [TBL] [Abstract][Full Text] [Related]
6. Immune modulation by interleukin-12 in tumor-bearing mice receiving vitamin D3 treatments to block induction of immunosuppressive granulocyte/macrophage progenitor cells. Prechel MM; Lozano Y; Wright MA; Ihm J; Young MR Cancer Immunol Immunother; 1996 May; 42(4):213-20. PubMed ID: 8665568 [TBL] [Abstract][Full Text] [Related]
7. Macrophage-mediated suppression of natural killer cell activity in mice bearing Lewis lung carcinoma. Young MR; Wheeler E; Newby M J Natl Cancer Inst; 1986 Apr; 76(4):745-50. PubMed ID: 3457207 [TBL] [Abstract][Full Text] [Related]
8. Treating tumor-bearing mice with low-dose gamma-interferon plus tumor necrosis factor alpha to diminish immune suppressive granulocyte-macrophage progenitor cells increases responsiveness to interleukin 2 immunotherapy. Pak AS; Ip G; Wright MA; Young MR Cancer Res; 1995 Feb; 55(4):885-90. PubMed ID: 7850804 [TBL] [Abstract][Full Text] [Related]
9. NK depletion results in increased CCL22 secretion and Treg levels in Lewis lung carcinoma via the accumulation of CCL22-secreting CD11b+CD11c+ cells. Mailloux AW; Clark AM; Young MR Int J Cancer; 2010 Dec; 127(11):2598-611. PubMed ID: 20198623 [TBL] [Abstract][Full Text] [Related]
10. Ineffective immune enhancement by IL-12 in tumor-bearing mice whose immune depression is mediated by suppressive granulocyte-macrophage progenitor cells. Prechel MM; Lozano Y; Wright MA; Ihm J; Young MR Cancer Lett; 1995 Jun; 92(2):235-42. PubMed ID: 7600536 [TBL] [Abstract][Full Text] [Related]
11. Myelopoiesis-associated immune suppressor cells in mice bearing metastatic Lewis lung carcinoma tumors: gamma interferon plus tumor necrosis factor alpha synergistically reduces immune suppressor and tumor growth-promoting activities of bone marrow cells and diminishes tumor recurrence and metastasis. Young MR; Wright MA Cancer Res; 1992 Nov; 52(22):6335-40. PubMed ID: 1423279 [TBL] [Abstract][Full Text] [Related]
13. Immunological hallmarks of cis-DDP-resistant Lewis lung carcinoma cells. Fedorchuk O; Susak Y; Rudyk M; Senchylo N; Khranovska N; Skachkova O; Skivka L Cancer Chemother Pharmacol; 2018 Feb; 81(2):373-385. PubMed ID: 29290023 [TBL] [Abstract][Full Text] [Related]
14. Myelopoiesis-associated suppressor-cell activity in mice with Lewis lung carcinoma tumors: interferon-gamma plus tumor necrosis factor-alpha synergistically reduce suppressor cell activity. Young MR; Young ME; Wright MA Int J Cancer; 1990 Aug; 46(2):245-50. PubMed ID: 2143498 [TBL] [Abstract][Full Text] [Related]
15. Antitumor mechanism of recombinant murine interleukin-12 vaccine. Yin X; Yan X; Yang Q; Cao H; Liang H Cancer Biother Radiopharm; 2010 Jun; 25(3):263-8. PubMed ID: 20578831 [TBL] [Abstract][Full Text] [Related]
16. Suppression of T cell proliferation by tumor-induced granulocyte-macrophage progenitor cells producing transforming growth factor-beta and nitric oxide. Young MR; Wright MA; Matthews JP; Malik I; Prechel M J Immunol; 1996 Mar; 156(5):1916-22. PubMed ID: 8596044 [TBL] [Abstract][Full Text] [Related]
17. Antibodies to colony-stimulating factors block Lewis lung carcinoma cell stimulation of immune-suppressive bone marrow cells. Young MR; Wright MA; Young ME Cancer Immunol Immunother; 1991; 33(3):146-52. PubMed ID: 1675153 [TBL] [Abstract][Full Text] [Related]
18. Prostaglandin E2-mediated inactivation of various killer lineage cells by tumor-bearing host macrophages. Parhar RS; Lala PK J Leukoc Biol; 1988 Dec; 44(6):474-84. PubMed ID: 2973508 [TBL] [Abstract][Full Text] [Related]
19. Changes in the activation and reconstitution of lymphocytes resulting from total-body irradiation correlate with slowed tumor growth. Miller GM; Kim DW; Andres ML; Green LM; Gridley DS Oncology; 2003; 65(3):229-41. PubMed ID: 14657597 [TBL] [Abstract][Full Text] [Related]
20. Decreased T-cell proliferation and skewed immune responses in LLC-bearing mice. Rashid RM; Achille NJ; Lee JM; Lathers DM; Young MR J Environ Pathol Toxicol Oncol; 2005; 24(3):175-92. PubMed ID: 16050802 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]